Brian Fricke, MD, director of cancer rehabilitation, at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, shares what side effects patients may face after cancer treatment and how receiving therapy services can help with pain and symptom management, improve physical function and reduce overall caregiver burden. Watch here    

Marcela Mazo Canola, MD, breast medical oncologist at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses how breast cancer has impacted the Hispanic/Latino population and the importance of breast cancer screenings. She also shares the signs of symptoms, along with the risk factors and what women can do to […]

This healthier version of pizza is high in fiber and protein which makes it a great alternative to the beloved traditional dish!

Start your day with this southwest vegetable frittata! This frittata is healthy, easy and full of flavor.

This smoothie is creamy, hydrating and a great calorie booster. It's filled with potassium, digestive enzymes, and will give you a great boost of energy.

UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy technology that will help investigators of the Mays Cancer Center study tumors and help researchers of the Greehey Children’s Cancer Research Institute to study childhood cancers.

The findings from recent research studies in pediatric cancer offer hope for drug development.

The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.

This delightful chocolate pudding with a surprise ingredient is a great option when you're craving something sweet. 

Daruka Mahadevan, MD, PhD, division chief, hematology-oncology, director of the Institute of Drug Development and associate director for clinical research at Mays Cancer Center at UT Health San Antonio and his team have identified a series of small molecule compounds that target an enzyme, MAP4K3, important to amino acid signaling in autophagy, impacting neurologic diseases and cancer.